Cortex Discovery
Cortex Discovery is a biotech company leveraging a proprietary AI foundation model to revolutionize preclinical drug discovery across all therapeutic areas. Their deep-learning model predicts therapeutic effects, off-target effects, and pharmacological properties by analyzing a vast curated database of 750 million biological data points for 2.5 million molecules. This enables rapid identification of high-quality compounds with higher chances of success, significantly accelerating drug development. Cortex offers service and milestone-based collaborations and has demonstrated validated compounds against diseases like COVID-19, HIV, and cancer. They also focus on longevity drug development targeting age-related disorders. Their technology includes virtual high-throughput screening, ADMET profiling, off-target screening, and AI-driven hit analog and de novo compound generation, positioning them as a leader in AI-powered drug discovery with proven lab validation and academic partnerships.
Cortex Discovery
Cortex Discovery is a biotech company leveraging a proprietary AI foundation model to revolutionize preclinical drug discovery across all therapeutic areas. Their deep-learning model predicts therapeutic effects, off-target effects, and pharmacological properties by analyzing a vast curated database of 750 million biological data points for 2.5 million molecules. This enables rapid identification of high-quality compounds with higher chances of success, significantly accelerating drug development. Cortex offers service and milestone-based collaborations and has demonstrated validated compounds against diseases like COVID-19, HIV, and cancer. They also focus on longevity drug development targeting age-related disorders. Their technology includes virtual high-throughput screening, ADMET profiling, off-target screening, and AI-driven hit analog and de novo compound generation, positioning them as a leader in AI-powered drug discovery with proven lab validation and academic partnerships.